ANTICYTOPLASMIC ANTIBODY - ANVISA Registration 10322610032

Access comprehensive regulatory information for ANTICYTOPLASMIC ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10322610032 and manufactured by HEMAGEN DIAGNÓSTICS. The registration is held by KIMENZ EQUIPAMENTOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, INOVA DIAGNOSTICS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10322610032
Registration Details
ANVISA Registration Number: 10322610032
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

ANTICORPO CITOPLASMATICO ANTI-NEUTROFILO (CANCA)EIA
Risk Class II

Registration Details

10322610032

25351140009201911

72791445000148

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Apr 08, 2019

VIGENTE

09/18/2025 19:00:01